What is it about?
Through this study we showed the influence of the use of different formulations of asparaginase on the overall and event-free survival of children with acute lymphocytic leukemia treated in Brazil. Children who received a formulation that, according to previous data from our group, did not reach therapeutic activity in most cases, had worse outcomes.
Photo by Caleb Woods on Unsplash
Why is it important?
These data serve as a warning about the importance of monitoring asparaginase activity and its clinical impact.
Read the Original
This page is a summary of: Influence of different asparaginase formulations in the prognosis of children with acute lymphocytic leukaemia in Brazil: a multicentre, retrospective controlled study, British Journal of Haematology, May 2021, Wiley, DOI: 10.1111/bjh.17494.
You can read the full text:
The following have contributed to this page